Benzbromarone    (DrugBank: Benzbromarone)

1 disease
IDDisease name (Link within this page)Number of trials
86Pulmonary arterial hypertension2

86. Pulmonary arterial hypertension    [ 1,083 clinical trials,   667 drugs,   (DrugBank: 122 drugs),   98 drug target genes,   185 drug target pathways]
Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 1,083 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-000709-38-AT
(EUCTR)
20/10/201528/07/2015Effects of the drug Benzbromaron on the pulmonary vesselsAcute Effects of Benzbromaron on the pulmonary circulation Pulmonary arterial hypertension
MedDRA version: 18.1;Level: PT;Classification code 10064911;Term: Pulmonary arterial hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Trade Name: Benzbromaron AL
Product Name: Benzbromaron
INN or Proposed INN: BENZBROMARONE
Medical University of GrazNULLNot RecruitingFemale: yes
Male: yes
Phase 2Austria
2NCT02790450
(ClinicalTrials.gov)
October 201530/5/2016Acute Effects of Benzbromaron on the Pulmonary CirculationAcute Effects of Benzbromaron on the Pulmonary CirculationIdiopathic Pulmonary Arterial HypertensionDrug: BenzbromaroneMedical University of GrazLudwig Boltzmann Institute for Lung Vascular ResearchCompleted18 Years90 YearsBoth10Phase 2Austria